Drug intelligence / Profile preview

Vitybelle

Development stage
Unknown
Lead developer
Aristo Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Vitybelle is a combined oral contraceptive (COC) containing the synthetic progestogen chlormadinone acetate and the synthetic estrogen ethinylestradiol. It is primarily indicated for the prevention of pregnancy and is also frequently prescribed for the treatment of moderate acne in women who require hormonal contraception. The mechanism of action involves the suppression of gonadotropin secretion from the pituitary gland, which inhibits ovulation, increases the viscosity of cervical mucus to impede sperm transport, and alters the endometrial lining to prevent implantation. Chlormadinone acetate is a derivative of progesterone that possesses significant anti-androgenic properties, allowing it to compete with endogenous androgens at the receptor level, thereby reducing sebum production and improving androgen-dependent skin conditions.

Brand names
Vitybelle
02

Targets

PR (Progesterone receptor)ER (Estrogen receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on Vitybelle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitybelle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call